Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Invion.
RELATED STOCKHEAD STORIES
Health & Biotech
Health: Amplia really gives a FAK about cancer as phase 1 trial still on track
Health & Biotech
Selvax cures cancer in dogs, says it’s eyeing an IPO
Health & Biotech
Invion says lasers can trigger anti-cancer immune response in mice
Health & Biotech
Dr Boreham’s Crucible: This is the only ASX-listed biotech in the photodynamic therapy game
Health & Biotech
Cancer Wars Part 1: These are the ASX small cap drugmakers that want to conquer cancer
Health & Biotech
Health: Invion may have found its break in Chinese dermatology
Health & Biotech
Check-up: Lasers and fatty livers won in biotech this month
News
Spies and corporate takeovers: what’s next for the China-Australia story?
Health & Biotech
Health: Fricken lasers shrink ovarian cancer (also look good on sharks)
Health & Biotech
Biotech: Invion closer to curing mice of spreading cancers; shares up 57pc
Health & Biotech
Health: Bubs gets national deal with Chemist Warehouse, extra China route, share spike
Health & Biotech
Fliers, flameouts and fakers: what happened in biotechland in 2018
Health & Biotech
Invion says its ovarian cancer cell killer is now 15x more deadly
Health & Biotech
Cancer fighter Invion offloads respiratory drugs into China spin-off
Health & Biotech
Here’s a bunch of top ASX respiratory stocks that will leave you breathless
News
Lunchtime ASX small cap wrap: who are the hot dogs so far today
Health & Biotech
